PTC Therapeutics, Inc. PTCT
$71.70
-0.38%
at last close
Financials (TTM)
- Revenue
- $1.01 billion
- Net Income
- $-38,382,000
- Net Margin
- -3.80%
- Return on Equity
- 23.21%
- Debt-to-Equity
- —
- P/E Ratio
- —
- Price / Book
- -36.19
- Price / Sales
- 5.93
Over the trailing twelve months, PTC Therapeutics, Inc. generated revenue of $1.01 billion and net income of $-38,382,000, a net margin of -3.80%.
At the last closing price of $71.70, PTCT trades at 5.93 times sales, with a market capitalization of $5.98 billion.
Key Stats
- Last Close
- $71.70
- Market Cap
- $5.98 billion
- 52-Week Range
- $43.17 – $90.87
- Average Volume
- 1.32 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.